Synthesis pattern of matrix metalloproteinases (MMPs) and inhibitors (TIMPs) in human explant organ cultures after treatment with latanoprost and dexamethasone

Eye (Basingstoke)

Volumn 14, Issue 3, 2000, Pages 375-383

  El Shabrawi, Yosuf ^a   Eckhardt, Martin ^a   Berghold, Andrea ^a   Faulborn, Jürgen ^a   Auboeck, Ludwig ^a   Mangge, Harald ^a   Ardjomand, Navid ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

Dexamethasone; Human explant organ cultures; Latanoprost; Matrix metalloproteinases; Tissue inhibitors of matrix metalloproteinases (TIMPs)

Indexed keywords

ANTIBODY; CORTICOSTEROID; DEXAMETHASONE; GELATINASE A; GELATINASE B; LATANOPROST; MATRIX METALLOPROTEINASE; PROSTAGLANDIN; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADULT; AGED; ARTICLE; CELL CULTURE; CILIARY BODY; CONTROLLED STUDY; DRUG EFFECT; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; ORGAN CULTURE; PIGMENT EPITHELIUM; TRABECULAR MESHWORK; ZYMOGRAPHY;

EID: 0033928855     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2000.92     Document Type: Article

References (32)

1. Camras CB, Aim A. Initial clinical studies with prostaglandins and their analogues. Surv Ophthalmol 1997; 41(Suppl 2); S61-8.
2. Lindsey JD, Kashiwagi K, Kashiwagi F, Weinreb RN. Prostaglandins alter extracellular matrix adjacent to human ciliary muscle cells in vitro. Invest Ophthalmol Vis Sci 1997; 38: 2214-23.
3. Weinreb RN, Kashiwagi K, Kashiwagi F, Tsukahara S, Lindsey JD. Prostaglandins increase matrix metalloproteinase release from human ciliary smooth muscle cells. Invest Ophthalmol Vis Sci 1997; 38: 2772-80.
4. Ocklind A. Effect of latanoprost on the extracellular matrix of the ciliary muscle: a study on cultured cells and tissue sections. Exp Eye Res 1998; 67: 179-91.
5. Krauss AH, Wiederholt M, Sturm A, Woodward DF. Prostaglandin effects on the contractility of bovine trabecular meshwork and ciliary muscle. Exp Eye Res 1997; 64: 447-53.
6. Hoyng PFJ, Rulo A, Greve E, Watson P, Aim A. The additive intraocular pressure-lowering effect of latanoprost in combined therapy with other ocular hypotensive agents. Surv Ophthalmol 1997; 41 (Suppl 2): S93-8.
7. Anthony TL, Pierce KL, Stamer WP, Regan JW. Prostaglandin F20< receptors in the human trabecular meshwork. Invest Ophthalmol Vis Sci 1998; 39: 315-21.
8. Samples JR, Alexander JP, Acott TS. Regulation of levels of human trabecular matrix metalloproteinases and inhibitor by interleukin-1 and dexamethasone. Invest Ophthalmol Vis Sci 1993; 34: 3386-95.
9. Rohen JW, Linner E, Witmer R. Electron microscopic studies on the trabecular meshwork in two cases of corticosteroid glaucoma. Exp Eye Res 1973; 17: 19-31.
10. Johnson D, Gottanka J, Flugel C, Hoffmann F, Futa R, Luon Drecoll E. Ultrastructural changes in the trabecular meshwork of human eyes treated with corticosteroids. Arch Ophthalmol 1997; 115: 375-83.
11. Roll P, O Benedikt. Elektronenoptische Untersuchung des Trabekelwerkes beim Kortikosteroidglaukom. Klin Monatsbl Augenheilkd 1979; 174: 421-8.
12. Lindsey JD, To HD, Weinreb RN. Induction of c-fos by prostaglandin F2 alpha in human ciliary smooth muscle cells. Invest Ophthalmol Vis Sci 1994; 35: 242-50.
13. Ocklind A, Lake S, Wentzel P, Nister M, Stjernschantz J. Localisation of prostaglandin Fzo< receptor messenger RNA and protein in the cynomolgus monkey eye. Invest Ophthalmol Vis Sci 1996; 37: 716-26.
14. Padgett LC, Lui GM, Werb Z, Lavail MM. Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 in the retinal pigment epithelium and interphotoreceptor matrix: vectorial secretion and regulation. Exp Eye Res 1997; 64: 927-38.
15. Rowe JA, Hattenhauer MG, Herman DC. Adverse side effects associated with latanoprost. Am J Ophthalmol 1997; 124: 683-5.
16. Warwar RE, Bullock JD, Ballal D. Cystoid macula edema and anterior uveitis associated with latanoprost use: experience and incidence in a retrospective review of 94 patients. Ophthalmology 1998; 105: 263-8.
17. Steen B, Sejersen S, Berglin L, Seregard 5, Kvanta A. Matrix metalloproteinases and metalloproteinase inhibitors in choroidal neovascular membranes. Invest Ophthalmol Vis Sci 1998; 39: 2194-200.
18. Acott TS, Kingsley PD, Samples JR, Van Buskirk EM. Human trabecular meshwork organ culture: morphology and glycosaminglycan synthesis. Invest Ophthalmol Vis Sci 1988; 29: 90-100.
19. Baumgartner J, Huber-Spitzy V, Grabner G, Mayr WR. HLA typing from human donor eyes. Graefes Arch Clin Exp Ophthalmol 1989; 227: 541-3.
20. Huang SH, Adamis AP, Wiederschain DG, Shima DT, Shing Y, Moses MA. Matrix metalloproteinases and their inhibitors in aqueous humor. Exp Eye Res 1996; 62: 481-90.
21. Ando H, Twining SS, Yue BJYT, Zhou X, Fini ME, Kaiya T, et al. MMPs and proteinase inhibitors in the human aqueous humor. Invest Ophthalmol Vis Sci 1993; 34: 3541-8.
22. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex in immunoperoxidase techniques. J Histochem Cytochem 1981; 29: 577-80.
23. Tang S, Scheiffarth OF, Stefani FH. Clinical and immunohistochemical correlations of herpetic keratitis with the expression of HLA-DR antigen. Graefes Arch Clin Exp Ophthalmol 1993; 231: 162-5.
24. Patelska B, Greenfield DS, Liebmann JM, Wand M, Kushnick H, Ritch R. Latanoprost for uncontrolled glaucoma in a compassionate case protocol. Am J Ophthalmol 1997; 124: 279-86.
25. Alm A, Camras CB, Watson PG. Phase III latanoprost studies in Scandinavia, the United Kingdom and the United States. Surv Ophthalmol 1997; 41 (Suppl 2): S105-10.
26. Bradley JM, Vranka J, Colvis CM, Conger DM, Alexander JP, Fisk AS, et al. Effect of matrix metalloproteinases activity on outflow in perfused human organ culture. Invest Ophthalmol Vis Sci 1998; 39: 2649-58.
27. Helm CJ, Holland GN. The effects of posterior sub-Tenon injection of triamcinolone acetonide in patients with intermediate uveitis. Am J Ophthalmol 1995; 120: 55-64.
28. Tripathi RC, Kirschner BS, Kipp M, Tripathi BJ, Slotwiner D, Borisuth NS, et al. Corticosteroid treatment for inflammatory bowel disease in pediatric patients increases intraocular pressure. Gastroenterology 1992; 102: 1957-61.
29. Synder RW, Stamer WD, Kramer TR, Seftor REP. Corticosteroid treatment and trabecular meshwork proteinases in cell and organ culture supernatants. Exp Eye Res 1993; 57: 461-8.
30. Matsubara M, Zieski JD, Fini ME. Mechanism of basement membrane dissolution preceding corneal ulceration. Invest Ophthalmol Vis Sci 1991; 32: 3221-37.
31. Gaton DD, Sagra T, Lindsey JD, Weinberg RN. Matrix metalloproteinase-1 localisation in the normal uveoscleral outflow pathway. Invest Ophthalmol Vis Sci 1999; 40: 363-9.
32. Di-Girolamo N, Verma MJ, McCluskey PI, Lloyd A, Wakefield D. Increased matrix metalloproteinases in the aqueous humor of patients and experimental animals with uveitis. Curr Eye Res 1996; 15: 1060-8.